Hyperfine (HYPR) Competitors $0.85 -0.09 (-9.59%) (As of 04:00 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends HYPR vs. ZYXI, LUNG, ELMD, CATX, PROF, DRTS, KRMD, SKIN, SGHT, and LAKEShould you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Zynex (ZYXI), Pulmonx (LUNG), Electromed (ELMD), Perspective Therapeutics (CATX), Profound Medical (PROF), Alpha Tau Medical (DRTS), KORU Medical Systems (KRMD), Beauty Health (SKIN), Sight Sciences (SGHT), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry. Hyperfine vs. Zynex Pulmonx Electromed Perspective Therapeutics Profound Medical Alpha Tau Medical KORU Medical Systems Beauty Health Sight Sciences Lakeland Industries Hyperfine (NASDAQ:HYPR) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, media sentiment, institutional ownership, earnings, profitability, valuation and risk. Which has more risk and volatility, HYPR or ZYXI? Hyperfine has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Zynex has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Which has stronger valuation & earnings, HYPR or ZYXI? Zynex has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHyperfine$13.26M5.17-$44.24M-$0.57-1.65Zynex$193.67M1.38$9.73M$0.1556.00 Does the media favor HYPR or ZYXI? In the previous week, Zynex had 3 more articles in the media than Hyperfine. MarketBeat recorded 5 mentions for Zynex and 2 mentions for Hyperfine. Hyperfine's average media sentiment score of 0.94 beat Zynex's score of 0.75 indicating that Hyperfine is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hyperfine 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zynex 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in HYPR or ZYXI? Zynex received 25 more outperform votes than Hyperfine when rated by MarketBeat users. Likewise, 58.00% of users gave Zynex an outperform vote while only 44.44% of users gave Hyperfine an outperform vote. CompanyUnderperformOutperformHyperfineOutperform Votes444.44% Underperform Votes555.56% ZynexOutperform Votes2958.00% Underperform Votes2142.00% Do insiders and institutionals have more ownership in HYPR or ZYXI? 15.0% of Hyperfine shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 29.4% of Hyperfine shares are held by company insiders. Comparatively, 52.1% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is HYPR or ZYXI more profitable? Zynex has a net margin of 2.49% compared to Hyperfine's net margin of -309.42%. Zynex's return on equity of 13.05% beat Hyperfine's return on equity.Company Net Margins Return on Equity Return on Assets Hyperfine-309.42% -57.54% -50.38% Zynex 2.49%13.05%3.78% Do analysts prefer HYPR or ZYXI? Hyperfine currently has a consensus target price of $1.60, indicating a potential upside of 70.23%. Zynex has a consensus target price of $14.00, indicating a potential upside of 66.67%. Given Hyperfine's higher possible upside, equities research analysts clearly believe Hyperfine is more favorable than Zynex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperfine 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Zynex 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryZynex beats Hyperfine on 14 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get Hyperfine News Delivered to You Automatically Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HYPR vs. The Competition Export to ExcelMetricHyperfineElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$68.57M$3.10B$5.14B$9.31BDividend YieldN/A1.73%4.81%4.06%P/E Ratio-1.6518.44135.1917.53Price / Sales5.1754.581,232.15140.37Price / CashN/A39.9140.6537.95Price / Book0.803.754.884.92Net Income-$44.24M$90.26M$118.97M$225.78M7 Day Performance-5.54%-3.87%15.41%-1.58%1 Month Performance11.23%2.12%15.47%6.67%1 Year Performance-12.97%8.57%34.58%22.48% Hyperfine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HYPRHyperfine2.4075 of 5 stars$0.85-9.6%$1.60+88.3%-12.2%$61.99M$13.26M-1.49190News CoverageZYXIZynex3.7717 of 5 stars$8.42+3.4%$14.00+66.3%-17.0%$268.18M$184.32M54.271,100LUNGPulmonx2.9259 of 5 stars$6.11+0.2%$12.75+108.7%-50.2%$241.27M$79.30M-4.15250ELMDElectromedN/A$28.42+0.9%N/A+171.1%$240.38M$57.06M39.14174CATXPerspective Therapeutics3.4368 of 5 stars$3.42-1.7%$15.14+342.8%N/A$231.15M$1.43M0.00116Positive NewsPROFProfound Medical2.6912 of 5 stars$7.26-1.9%$13.75+89.4%-23.9%$218.02M$7.20M-5.52150Analyst RevisionHigh Trading VolumeDRTSAlpha Tau Medical2.1157 of 5 stars$3.09+0.7%$8.00+158.9%+13.5%$216.07MN/A-7.1480News CoverageGap UpKRMDKORU Medical Systems1.448 of 5 stars$4.29-0.2%$4.13-3.8%+74.6%$196.65M$28.52M-17.2080SKINBeauty Health1.7615 of 5 stars$1.55-2.2%$2.55+65.0%-43.5%$191.77M$398M-3.761,030Gap UpSGHTSight Sciences3.3512 of 5 stars$3.66+2.2%$5.12+39.9%+8.7%$185.78M$81.06M-3.51210LAKELakeland Industries4.6273 of 5 stars$23.66+4.2%$26.50+12.0%+40.2%$175.23M$151.82M-252.221,750Options VolumeNews Coverage Related Companies and Tools Related Companies Zynex Alternatives Pulmonx Alternatives Electromed Alternatives Perspective Therapeutics Alternatives Profound Medical Alternatives Alpha Tau Medical Alternatives KORU Medical Systems Alternatives Beauty Health Alternatives Sight Sciences Alternatives Lakeland Industries Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HYPR) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperfine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
